Showing 7241-7250 of 19323 results for "".
Preventing Allergic Reactions to Peanuts with a Cancer Drug
https://reachmd.com/programs/clinicians-roundtable/preventing-allergic-reactions-to-peanuts-with-a-cancer-drug/18012/Can a blood cancer drug potentially prevent allergic reactions to peanuts? Tune in to find out.Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
https://reachmd.com/programs/neurofrontiers/diagnosing-treating-neurocognitive-disorders-in-the-psychiatric-setting/15385/How can we accurately diagnose neurocognitive disorders? Tune in to this recap from the 2023 American Psychiatric Association Annual Meeting.Clinical and Structural Correlates of COVID-19 Hardship in Latino Adults
https://reachmd.com/programs/clinicians-roundtable/clinical-and-structural-correlates-of-covid-19-hardship-in-latino-adults/36417/Best Contact Lens Strategies of 2025
https://reachmd.com/programs/modern-optometry/best-contact-lens-strategies-of-2025/39996/Chasing Answers: Is There a Link Between Exercise & Psoriasis?
https://reachmd.com/programs/spotlight-psoriasis/chasing-answers-is-there-a-link-between-exercise-and-psoriasis/12255/Can cardiorespiratory exercise prevent the onset of autoimmune diseases such as psoriasis?Recognizing Alzheimer's Disease at the Earliest Stages: Key Signs and Symptoms
https://reachmd.com/programs/alzheimers-disease-towards-early-detection/recognizing-alzheimers-disease-earliest-stages-key-signs-and-symptoms/8319/Dr. Howard Fillit from the Alzheimer's Drug Discovery Foundation discusses keys to early recognition for Alzheimer's disease.Advances in Cell-Based Therapy for MS
https://reachmd.com/programs/neurofrontiers/advances-cell-based-therapy-ms/54256/Cxplore how cell-based therapies are reshaping treatment strategies for multiple sclerosis (MS). Hear from Dr. Mark Freedman as he examines the scientific rationale behind emerging strategies. Dr. Freedman is a Professor of Medicine in Neurology at the University of Ottawa and a Senior ScienExamining Unmet Needs in Paroxysmal Nocturnal Hemoglobinuria
https://reachmd.com/programs/project-oncology/examining-unmet-needs-in-paroxysmal-nocturnal-hemoglobinuria/48877/What are the current treatment options for patients with PNH? And what are the limitations?Examining the Treatment Paradigm for Paroxysmal Nocturnal Hemoglobinuria
https://reachmd.com/programs/project-oncology/examining-the-treatment-paradigm-for-paroxysmal-nocturnal-hemoglobinuria/48880/Join us as we take a closer look at the current treatment options available for paroxysmal nocturnal hemoglobinuria.Closing Meningococcal Protection Gaps: The Case for Combination Vaccines
https://reachmd.com/programs/vaccination/closing-meningococcal-protection-gaps-the-case-for-combination-vaccines/37108/Despite high uptake of the quadrivalent meningococcal ACWY vaccine among adolescents, significant protection gaps remain, particularly against serogroup B. That’s why Dr. Ruth Carrico joins us to examine key challenges in adolescent vaccine delivery and how newer pentavalent vaccines covering all fi